News & Updates

Show Multimedia Only
Real-world study favours ritonavir-based regimens for hospitalized COVID-19 patients

Real-world study favours ritonavir-based regimens for hospitalized COVID-19 patients

21 Oct 2024 byAudrey Abella

In a real-world analysis evaluating four oral antiviral agents for the treatment of COVID-19, two ritonavir-based regimens fared better than molnupiravir and azvudine in reducing hospital stay among patients hospitalized for mild or moderate disease.

21 Oct 2024